Tim Watts, CFO at Shield Therapeutics #STX presenting at our Life Sciences Investor Briefing Watch Now


Latest Media


RNS VIDEO: Reabold Resources #RBD raise £6M and take stake in Danube Petroleum

Reabold Resources Co-Chief Executives Stephen Williams and Sachin Oza have just successfully raised 'approximately six million pounds' to invest in their innovative strategy. #RBD have also today ...


#PHARMA: Therapix Biosciences are developing 'medicinal cannabis' for Tourette's and sleep apnea

Josh Blacher, CFO at Therapix Biosciences, describes how his company are developing a therapeutic approach to obstructive sleep apnea, and in parallel are developing a synthetic cannabinoid-based ...


#PHARMA: Quantum Genomics to launch new class of high blood pressure drug

Lionel Segard is Chairman & CEO of Quantum Genomics, a French biotech company launched 11 years ago. Quantam are developing 1st in class drugs to treat hypertension and chronic heart ...


#PHARMA: Want to invest in PDL, the 'new Berkshire Hathaway' for Health Care?

Peter Garcia, the CFO at PDL BioPharma explains that in his view, PDL is 'unique'. Located in Lake Tahoe, Nevada, PDL is a publicly traded private equity group listed on Nasdaq: #PDLI. 'PDL allows ...


#PHARMA: NeuroVive are groundbreaking specialists in mitochondrial treatments

Erik Kinnman, CEO of Swedish biotech company NeuroVive Pharmaceutical, says that his company are at the forefront of research into mitochondrial medicine, which is the subject of growing ...


#PHARMA: Volition expects to market 'revolutionary' colo-rectal cancer blood test Q3 2018

Cameron Reynolds, Volition CEO, told London South East he expects to hit significant clinical test milestones in 2018 and to get a CE Mark and to begin selling their colorectal cancer blood test in ...


#PHARMA: Race Oncology has a successful track record of profitably recycling old drugs

Peter Molloy, CEO at Race Oncology explains how his business speeds up taking drugs to market. Race look for old drug assets which have been developed and discarded by big pharma companies who chose ...


#PHARMA: Heat Biologics - a 'totally game-changing' lung cancer treatment, Phase II data Q3 2018

Heat Biologics is an immunotherapy cancer company based in North Carolina,and listed on Nasdaq: HTBX. Heat develop drugs for non small-cell lung cancer and are in Phase II development trials using a ...


#PHARMA: Neuvolution, a Swedish/Danish biotech, 'expect partnership agreements within 3/12 months'

Henrik Simonsen, CFO, Nuevolution explains that his biotech company is listed on the Nasdaq First North Premier Exchange, a Stockholm-based growth stock exchange. Neuvolution have unique ...


EXCLUSIVE: President Energy, a profitable growth business, looks to double production by acquisition

PRESIDENT ENERGY: Peter Levine, CEO and Chairman, sums up President as 'a growth business on income, profitability and cash'. It is looking to double production from the current 2400 bopd organically ...

Login to your account

Don't have an account? Click here to register.